Clinical trial
Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II…
NCT00062309 · Fox Chase Cancer Center, Other · Completed
Key facts
| NCT number | NCT00062309 |
|---|---|
| Title | Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer |
| Official title | A Phase III Intensity Modulated Radiotherapy Dose Escalation Trial for Prostate Cancer Using Hypofractionation |
| Lead sponsor | Fox Chase Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Radiation |
| Interventions | radiation therapy |
| Enrollment | 307 |
| Start date | Jun 1, 2002 |
| Primary completion | May 1, 2006 |
| First posted | Jun 6, 2003 |
| Last update posted | Mar 3, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: